How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

Shirley Wang; William I. Jaffe; Ariana L. Smith

doi:10.1002/nau.70290

April 8, 2026Neurourology and UrodynamicsOpen Access

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to explore how to personalize the delivery of botulinum toxin-A for optimizing treatment of neurogenic lower urinary tract dysfunction.
Examined various neurologic etiologies affecting treatment response
Evaluated the functional status of patients prior to treatment
Developed individualized treatment strategies based on assessment results
Individualized treatment strategies led to better health outcomes
Tailoring therapy improved patient satisfaction
Greater effectiveness observed in patients with specific neurologic conditions

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This investigation demonstrates improved outcomes by personalizing botulinum toxin-A treatment for neurogenic lower urinary tract dysfunction, indicating the importance of tailored strategies.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/69d896566c1944d70ce07a7e https://doi.org/10.1002/nau.70290

View Full Paper

Ask AI

Bookmark

Share

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading